miR-150 inhibits terminal erythroid proliferation and differentiation.

Zhiwei Sun,Ye Wang,Xu Han,Xielan Zhao,Yuanliang Peng,Yusheng Li,Minyuan Peng,Jianhui Song,Kunlu Wu,Shumin Sun,Weihua Zhou,Biwei Qi,Chufan Zhou,Huiyong Chen,Xiuli An,Jing Liu
DOI: https://doi.org/10.18632/oncotarget.5824
2015-01-01
Oncotarget
Abstract:MicroRNAs (miRNAs), a class of small non-coding linear RNAs, have been shown to play a crucial role in erythropoiesis. To evaluate the indispensable role of constant suppression of miR-150 during terminal erythropoiesis, we performed miR-150 gain-and loss-of-function experiments on hemin-induced K562 cells and EPO-induced human CD34(+) cells. We found that forced expression of miR-150 suppresses commitment of hemoglobinization and CD235a labeling in both cell types. Erythroid proliferation is also inhibited via inducing apoptosis and blocking the cell cycle when miR-150 is overexpressed. In contrast, miR-150 inhibition promotes terminal erythropoiesis. 4.1 R gene is a new target of miR-150 during terminal erythropoiesis, and its abundance ensures the mechanical stability and deformability of the membrane. However, knockdown of 4.1 R did not affect terminal erythropoiesis. Transcriptional profiling identified more molecules involved in terminal erythroid dysregulation derived from miR-150 overexpression. These results shed light on the role of miR-150 during human terminal erythropoiesis. This is the first report highlighting the relationship between miRNA and membrane protein and enhancing our understanding of how miRNA works in the hematopoietic system.
What problem does this paper attempt to address?